Skip to main content

Risk of fragility fracture among patients with sarcoidosis: a population-based study 1976–2013

Osteoporosis International volume 28, pages 1875–1879 (2017)Cite this article

Abstract

Summary

Incidence of fragility fracture of a population-based cohort of 345 patients with sarcoidosis was compared with age and sex-matched comparators. The incidence of fragility fracture was higher among patients with sarcoidosis with hazard ratio (HR) of 2.18.

Introduction

Several chronic inflammatory disorders increase the risk of fragility fracture. However, little is known about the risk of fragility fracture in patients with sarcoidosis.

Methods

This study was conducted using a previously identified population-based cohort of 345 patients with incident sarcoidosis from Olmsted County, Minnesota. Diagnosis of sarcoidosis required physician diagnosis supported by biopsy showing non-caseating granuloma, radiographic evidence of intrathoracic sarcoidosis, and compatible clinical presentations without evidence of other granulomatous diseases. Sex and age-matched subjects randomly selected from the same underlying population were used as comparators. Medical records of cases and comparators were reviewed for baseline characteristics and incident fragility fracture.

Results

Fragility fractures were observed in 34 patients with sarcoidosis, corresponding to a cumulative incidence of 5.6% at 10 years, while 18 fragility fractures were observed among comparators for a cumulative incidence of 2.4% at 10 years. The HR of fragility fractures among cases compared with comparators was 2.18 (95% confidence interval [CI], 1.23–3.88). The risk of fragility fracture by site was significantly higher among patients with sarcoidosis, and was due to a higher rate of distal forearm fracture (HR 3.58; 95% CI 1.53–8.40). Statistically non-significant increased risk was also observed in proximal femur (HR 1.66; 95% CI 0.45–6.06) and proximal humerus (HR 3.27; 95% CI 0.66–16.21). Risk of vertebral fracture was not increased (HR 1.00; 95% CI 0.32–3.11).

Conclusion

Patients with sarcoidosis have an increased risk of fragility fracture which is primarily driven by the higher incidence of distal forearm fracture.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1

References

  1. Chad D (2012) Bone loss in rheumatoid arthritis: systemic, periarticular, and focal. Clin Rheumatol Rep 14:231–237

    Article  Google Scholar 

  2. van Staa T, Geusens P, Bijlsma JW, Leufkens HG, Cooper C (2006) Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheum 54:3104–3112

    Article  PubMed  Google Scholar 

  3. Almehed K, Hetenyi S, Ohlsson C, Carlsten H, Forsblad-d’Elia H (2010) Prevalence and risk factors of vertebral compression fractures in female SLE patients. Arthritis Res Ther 12:R153

    Article  PubMed  PubMed Central  Google Scholar 

  4. Van Staa TP, Cooper C, Brusse LS, Leufkens H, Javaid MK, Arden NK (2003) Inflammatory bowel disease and the risk of fracture. Gastroenterology 125:1591–1597

    Article  PubMed  Google Scholar 

  5. Chen ES, Moller DR (2008) Etiology of sarcoidosis. Clin Chest Med 29:365–377

    CAS  Article  PubMed  Google Scholar 

  6. Newman LS, Rose CS, Bresnitz EA et al (2004) A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med 170:1324–1330

    Article  PubMed  Google Scholar 

  7. Morimoto T, Azuma A, Abe S et al (2008) Epidemiology of sarcoidosis in Japan. Eur Resp J 31:372–379

    CAS  Article  Google Scholar 

  8. Cozier YC, Berman JS, Palmer JR, Boggs DA, Serlin DM, Rosenberg L (2011) Sarcoidosis in black women in the United States: data from the black women’s health study. Chest 139:144–150

    Article  PubMed  Google Scholar 

  9. Chen ES, Moller DR (2011) Sarcoidosis—scientific progress and clinical challenges. Nat Rev Rheumatol 7:457–467

    CAS  Article  PubMed  Google Scholar 

  10. Saidenberg-Kermanac’h N, Semerano L, Nunes H et al (2014) Bone fragility in sarcoidosis and relationship with calcium metabolism disorders: a cross sectional study on 142 patients. Arthritis Res Ther 16:R78

    Article  PubMed  PubMed Central  Google Scholar 

  11. Heijckmann A, Drent M, Dumitrescu B et al (2008) Progressive vertebral deformities despite unchanged bone mineral density in patients with sarcoidosis: a 4-year follow-up study. Osteoporos Int 19:839–847

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  12. Bours S, de Vries F, van den Bergh JPW et al (2016) Risk of vertebral and non-vertebral fractures in patients with sarcoidosis: a population-based cohort. Osteoporos Int 27:1603–1610

    CAS  Article  PubMed  Google Scholar 

  13. Ungprasert P, Carmona EM, Utz JP et al (2016) Epidemiology of sarcoidosis 1946-2013: a population-based study. Mayo Clin Proc 91:183–188

    Article  PubMed  Google Scholar 

  14. Rocca WA, Yawn BP, St. Sauver JL, Grossardt BR, Melton LJ 3rd (2012) History of the Rochester Epidemiology Project: half a century of medical records linkage in a U.S. population. Mayo Clin Proc 87:1202–1213

    Article  PubMed  PubMed Central  Google Scholar 

  15. Gooley TA, Leisenring W, Crowley J et al (1999) Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 18:695–706

    CAS  Article  PubMed  Google Scholar 

  16. Alzahrani K, Gandhi R, Davis A, Mahomed N (2010) In-hospital mortality following hip fracture care in southern Ontario. Can J Surg 53:294–298

    PubMed  PubMed Central  Google Scholar 

  17. Frost SA, Nguyen ND, Black DA, Eisman JA, Nguyen TV (2011) Risk factors for in-hospital post-hip fracture mortality. Bone 49:553–558

    Article  PubMed  Google Scholar 

  18. Tervonen S, Karjalainen P, Valta R (1974) Bone mineral density in sarcoidosis. Acta Med Scand 196:497–503

    CAS  Article  PubMed  Google Scholar 

  19. Sipahi S, Tuzun S, Ozaras R et al (2004) Bone mineral density in women with sarcoidosis. J Bone Miner Metab 22:48–52

    Article  PubMed  Google Scholar 

  20. McLean R (2009) Proinflammatory cytokines and osteoporosis. Curr Osteoporos Rep 7:134–139

    Article  PubMed  Google Scholar 

  21. Frost SA, Nguyen ND, Center JR, Eisman JA, Nguyen TV (2009) Timing of repeat BMD measurements: development of an absolute risk-based prognostic model. J Bone Miner Metab 24:1800–1807

    Article  Google Scholar 

  22. Curtis EM, van der Velde R, Moon RJ et al (2016) Epidemiology of fractures in the United Kingdom 1988–2012: variation with age, sex, geography, ethnicity and socioeconomic status. Bone 87:19–26

    Article  PubMed  PubMed Central  Google Scholar 

  23. Prior JC, Langsetmo L, Lentle BC et al (2015) Ten-year incident osteoporosis-related fractures in the population-based Canadian Multicentre Osteoporosis Study: comparing site and age-specific risks in women and men. Bone 71:237–243

    Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

  1. Division of Rheumatology, Department of Internal Medicine, Mayo Clinic College of Medicine and Science, 200 First Avenue SW, Rochester, MN, 55905, USA

    P. Ungprasert, C. S. Crowson & E. L. Matteson

  2. Division of Biomedical Informatics, Department of Health Science Research, Mayo Clinic College of Medicine and Science, Rochester, MN, 55905, USA

    C. S. Crowson

  3. Division of Epidemiology, Department of Health Science Research, Mayo Clinic College of Medicine and Science, Rochester, MN, 55905, USA

    E. L. Matteson

Authors
  1. P. Ungprasert
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. S. Crowson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. L. Matteson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P. Ungprasert.

Ethics declarations

Approval for this study was obtained from the institutional review boards of Mayo Clinic and Olmsted Medical Center. The need for informed consent was waived.

Funding

This study was made possible using the resources of the Rochester Epidemiology Project, which is supported by the National Institute on Aging of the National Institutes of Health under Award Number R01AG034676, and CTSA Grant Number UL1 TR000135 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Conflicts of interest

None.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Ungprasert, P., Crowson, C.S. & Matteson, E.L. Risk of fragility fracture among patients with sarcoidosis: a population-based study 1976–2013. Osteoporos Int 28, 1875–1879 (2017). https://doi.org/10.1007/s00198-017-3962-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-017-3962-y

Keywords

  • Epidemiology
  • Fragility fracture
  • Glucocorticoids
  • Sarcoidosis